Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gastric Fundal Mucosal Ablation for Weight Management in Patients Stopping Glucagon-like Peptide-1 Receptor Agonists

NCT06734312 is registered in ClinicalTrials.gov with Dr. Christopher McGowan as lead sponsor.

NCT NCT06734312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06734312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gastric Fundal Mucosal Ablation for Weight Management in Patients Stopping Glucagon-like Peptide-1 Receptor Agonists
Lead sponsor
Dr. Christopher McGowan
Phase
Not applicable
Overall status
Recruiting
Start date
January 1, 2025
Completion date
June 30, 2026
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ablation techniques, glp-1, obesity and obesity-related medical conditions, obesity and overweight, obesity prevention, obesity recidivism